Mayo Clinic Pharmacy Grand Rounds

By Mayo Clinic

What's Mayo Clinic Pharmacy Grand Rounds about?

A weekly podcast for pharmacists, physicians, physician assistants, and nurse practitioners who are interested in learning more about clinical pharmacology topics. To claim pharmacology CE credit or to get a copy of presentation slides, visit https://ce.mayo.edu/pharmacypodcast. Produced by @MayoMedEd. Hosted by @garrett_schramm.

Download our free app to listen on your phone

Mayo Clinic Pharmacy Grand Rounds episodes:

06.26.2024
Scratching the Itch: The Role of the Pharmacist in De-Labeling Antimicrobial Agents
Matt Neumann, PharmD outlines recommendations to manage patients with penicillin and other antimicrobial allergy labels. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on X @MayoMedE
06.19.2024
Is Rate Control the Rate-limiting Step in Management of Atrial Fibrillation? Rate versus Rhythm Control with a Focus on Antiarrhythmic Drugs
Alyssa Pitterle, PharmD compares rate and rhythm control in the management of atrial fibrillation with a focus on pharmacotherapy. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online...
06.12.2024
When is Seizure Prophylaxis Indicated in Traumatic Brain Injury: Seizing the Opportunity
Lauren Metropulos, PharmD will review seizure prophylaxis in traumatic brain injury. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on X @MayoMedE
06.05.2024
Get Psyched: Legislative Approval of Medical Psychedelics and their Implications
Natalie Hagy, PharmD, discusses medical use of psychedelics, including legislative and practical considerations for states and hospitals For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on X @MayoMedE
05.29.2024
Tirzepatide: Weighing the Options
Mickenzie Meyers, PharmD shares insights on pharmacotherapeutic approaches to weight loss. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on X @MayoMedE
05.22.2024
Going Against the Graine: Triptans and Cardiovascular Disease
Jordyn Erkel, PharmD reviews the connection between migraines and cardiovascular disease. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on X at @MayoMedE
05.15.2024
A Brighter Future: Exploring the Role of Brentuximab vedotin in Pediatric Hodgkin’s Lymphoma
Taylor Gullickson, PharmD explores the role of brentuximab vedotin in pediatric Hodgkin’s lymphoma. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on X at @MayoMedE
05.08.2024
Transplanting New Ideas: Updates in Cytomegalovirus Prophylaxis Solid Organ Transplantation
Kennedy Concannon, PharmD discusses cytomegalovirus prophylaxis in solid organ transplantation. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
03.13.2024
Infusion Confusion: Defining the Role of Prolonged Infusion Beta-Lactams
Micaela Warfield, PharmD evaluates the role of prolonged infusion of beta-lactam antibiotics. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
03.06.2024
Breathing New Life into COPD Exacerbation Management
Katie Bye, PharmD provides insights on the management of COPD exacerbations. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
02.28.2024
Pumping Iron: IV Iron Replacement in HFrEF
Will Carns, PharmD reviews the role of intravenous iron in the treatment of heart failure with reduced ejection fraction. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online...
02.21.2024
Buprenorphine for Opioid Use Disorders: Should you Stop Periop?
Julia Branger, PharmD discusses use of buprenorphine in the perioperative period. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
02.14.2024
Infectious Risk with Advanced Therapies in Inflammatory Bowel Disease
Megan Edwards, PharmD shares insights on navigating infection risk with advanced therapies for inflammatory bowel disease. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
02.07.2024
Starving for Answers: Parenteral Nutrition in the Critically Ill
Brandy Hernandez, PharmD reviews approaches to nutritional need assessment in critical care. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
01.31.2024
Statin Intolerance and Clear Alternatives
Andrea Aguayo, PharmD provides insights on statin intolerance and alternative approaches. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
01.24.2024
Nirsevimab: Prevent RSV or Let it Be?
Kimberly James, PharmD shares developments on respiratory syncytial virus (RSV) prevention in infants. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
01.17.2024
Starting off STRONG: Optimizing Heart Failure Treatment at Transitions of Care
Krysta Larson, PharmD provides updates on heart failure treatment strategies in transitions of care. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
01.10.2024
When Drugs BITE Back: Managing Toxicities of Bispecific T-Cell Engagers
Jenna Puttkamer, PharmD shares insights into toxicity management of bispecific t-cell engagers. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
12.13.2023
Colchi(seen) to Reduce Cardiovascular Risk in Established ASCVD
Maggie Ruschmeyer, PharmD reviews the evidence in colchicine for secondary prevention of ASCVD. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
12.06.2023
It’s Not All Negative: Antibody Drug Conjugates in HER-2 Low Breast Cancer
Brianna Chambers, PharmD describes the landscape for HER-2 low classification in the treatment of breast cancer. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
11.29.2023
The Intensive Approach: Updates for Blood Pressure Control in Intracerebral Hemorrhage
Allie Curran, PharmD reviews blood pressure management strategies in intracerebral hemorrhage. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
11.15.2023
My, Oh, Myocarditis: More to Monitor for Clozapine?
Caitlin Schanz, PharmD discusses considerations for clozapine-induced myocarditis. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
11.08.2023
Going Viral! Reactivation of Viral Infections Following Cancer Treatment
Abdullah Al-Ajmi, PharmD, BCPS reviews approaches to viral reactivation following cancer treatment. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
11.01.2023
Don’t Lose Your Nerve: Supporting the Denervated Heart after Cardiac Transplantation
Tanner Melton, PharmD reviews pharmacologic management of post cardiac transplant. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
10.25.2023
Shocking Update: The Use of Fludrocortisone in Septic Shock
Hailey Thompson, PharmD shares SHOCKing updates on the use of corticosteroids in septic shock. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
10.18.2023
Bad Blood: Anemia Management Updates in the Setting of Chronic Kidney Disease
Mark Layden, PharmD, MBA shares the place in therapy for hypoxia-inducible factor prolyl hydroxylase inhibitors and other general approaches to anemia management in chronic kidney disease. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with...
10.11.2023
A Rumble in the Fungal Jungle: Review of the New Antifungal Agents
Natalie T. Hagy, PharmD shares new antifungal agents in the pipeline, their novel mechanisms of action, and available formulations. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional...
10.04.2023
Lost in the ECMO Chamber: Pharmacokinetics in Critical Illness
Ming May Zhang, PharmD reviews pharmacokinetic considerations in extracorporeal membrane oxygenation. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
09.13.2023
Must be mAb on the Brain: A New Hope for Alzheimer’s Disease
Hailey Thompson, PharmD, reviews primary literature and shares updates on the role of monoclonal antibody therapies in the treatment of Alzheimer’s Disease. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School...
09.06.2023
GPS for APS: Navigating Anticoagulation in Antiphospholipid Syndrome
Caitlin Schanz, PharmD discusses antiphospholipid syndrome, with a focus on data comparing direct oral anticoagulants versus warfarin as anticoagulation strategies in these patients. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s...
08.30.2023
Waving Goodbye to the X Waiver: Reassessing Medication Treatment for Opioid Use Disorder
Tanner Melton, PharmD reviews literature on buprenorphine and methadone in treating opioid use disorder. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
08.23.2023
Give it a Shot! Long-Acting Injectables in HIV Therapy
Christopher Cahoon, PharmD elucidates the literature pertaining to injectable cabotegravir and rilpivirine as HIV therapy options. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
08.16.2023
Taking the LEAD? Dual Pathway Inhibition Therapy for Lower Extremity Arterial Disease
Shienna Braga, PharmD examines the literature pertaining to dual pathway inhibition for lower extremity arterial disease. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
08.09.2023
What’s Been ‘Flozin On: Updates in Outpatient Management of Chronic Kidney Disease
Lauren Stonerock, PharmD describes updates in outpatient management of chronic kidney disease. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
08.02.2023
Celebrating diversity: challenges and strategies to promote pharmacogenomics translation across populations
Serena Mitaly, PharmD shares strategies for pharmacogenomic research translation to reduce health disparities. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
07.26.2023
What’s the Best for CRS?
Devon Stonerock, PharmD, Uzo Abajue, PharmD and Divya Khandekar, PharmD describe cytokine release syndrome (CRS), the literature surrounding CRS and options for CRS management. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo...
07.19.2023
Pitter Patter, Let’s Get ATTR: Medications for Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Kelli Herrin, PharmD reviews the pathophysiology of transthyretin amyloidosis cardiomyopathy and provides updates on medication options. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
07.12.2023
Updates on the Clozapine REMS Program: An Important Relic or Fool’s Gold of Safety?
Jonathan Leung, PharmD, BCPS, BCPP provides updates on the clozapine REMS program, reviews the therapeutic benefits of clozapine, as well as key adverse events. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the...
07.05.2023
On Another Level: The Role of Therapeutic Drug Monitoring in Inflammatory Bowel Disease
Sarah A. Chase, PharmD reviews the pathophysiology and current treatment strategies for inflammatory bowel disease, defines the clinical application of therapeutic drug monitoring of biologic therapies used in inflammatory bowel disease and discusses biologic therapy optimization based on therapeutic drug...
06.28.2023
All-In on Insulin? Use of High-Dose Insulin Euglycemic Therapy in Calcium Channel Blocker Overdose
Kyle A. Hess, PharmD, BCPS Twitter: @KyleHessPharmD describes the pathophysiology of calcium channel blocker overdose, explains the rationale for use of insulin-euglycemic therapy in calcium channel blocker overdose and identifies differences between the pathophysiology of dihydropyridine overdose and non-dihydropyridine overdose. For...
06.21.2023
Measuring Value in Drug Therapy
Scott A. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA (Twitter: @sasoefje) describes the relationship between value and quality, defines quality and how quality measures will impact healthcare in the coming years, and demonstrates how organizations may use quality measures to improve...
06.14.2023
Verification Decision Support: May AI Take Your Order?
Benjamin J. Anderson, PharmD, MPH, FASHP and Diana J. Schreier, PharmD, MBA, BCPS recognize the history and regulations for prospective medication order review, describe the technical landscape for verification decision support and explore real-world verification decision support outcomes. For more pharmacy...
06.07.2023
A Hard-Pressed Debate: The Role of Terlipressin in Hepatorenal Syndrome
Nikitha Yagnala, PharmD and Andy J. Jatis, PharmD, BCPS describe the pathophysiology of hepatorenal syndrome (HRS), describe the pathophysiology of hepatorenal syndrome (HRS) and outline an optimal patient care plan for the management of HRS. For more pharmacy content, follow Mayo...
05.31.2023
Freezing Ethylene Glycol Toxicity
Kamryn R. Storm, PharmD (Twitter @KRStorm) outlines the mechanism of toxicity for ethylene glycol, identifies clinical findings of ethylene glycol toxicity and selects treatment regimens for suspected ethylene glycol toxicity. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or...
05.24.2023
Emerging Antibiotics – Tetra(cycle)ine Back to Basics
Ashton C. Praska, PharmD (Twitter @ashpraka) describes tetracycline resistance mechanisms utilized by bacteria, identifies how Omadacycline/Eravacycline can overcome common tetracycline resistance mechanisms and identifies clinical scenarios where Omadacycline/Eravacycline could be considered for use. For more pharmacy content, follow Mayo Clinic Pharmacy...
05.17.2023
Pharmacotherapy for the Treatment of Obesity
Kristina M. Thurber, PharmD, BCPS recognizes pharmacotherapy for the treatment of obesity and explain mechanisms of action for each class, discusses and compares clinical data and weight loss outcomes for common treatment options, and determines an optimal pharmacologic regimen for...
05.10.2023
Off the Chain: The Drug Supply Chain and Medication Shortages
Jo Ann Leal, PharmD (Twitter @JoJoPharmD) describes the key components of the drug supply chain and the impact of drug shortages, identifies common organizational strategies used to mitigate drug shortages and evaluates recent national efforts to stabilize the drug supply...
05.03.2023
Clostridioides difficile Infection: Do We C the Diff-erence in Preventing Recurrence?
Andrew (Andy) F. Wiener, PharmD (Twtitter @andywiener) describes the pathogenesis and risk factors of C. diff infection and recurrence, reviews the preferred treatment modalities for prevention of C. diff recurrence and describes the cost-benefit analysis supporting guideline-directed management of C....
04.26.2023
Pharmacologic Treatment of Drug Resistant Hypercholesterolemia
Seth M. Kriha, PharmD identifies guideline recommended treatment to reduce LDL-C, evaluates landmark clinical trials for novel therapeutic agents indicated for treatment resistant hypercholesterolemia and develops a pharmacologic care plan for a patient with treatment resistant hypercholesterolemia. For more pharmacy content,...
04.05.2023
It’s Going Tibia Okay: Supportive Bone Health in Oncology
Christopher R. Cahoon, PharmD defines the importance of optimizing bone health in patients with bone metastases and lytic lesions, describes preferred bone-targeted therapy for patients with malignancy-associated bone disease and discusses the safety limitations associated with bisphosphonates and RANKL inhibitors. For...

What's Mayo Clinic Pharmacy Grand Rounds about?

Download our free app to listen on your phone

Mayo Clinic Pharmacy Grand Rounds episodes:

Scratching the Itch: The Role of the Pharmacist in De-Labeling Antimicrobial Agents

Is Rate Control the Rate-limiting Step in Management of Atrial Fibrillation? Rate versus Rhythm Control with a Focus on Antiarrhythmic Drugs

When is Seizure Prophylaxis Indicated in Traumatic Brain Injury: Seizing the Opportunity

Get Psyched: Legislative Approval of Medical Psychedelics and their Implications

Tirzepatide: Weighing the Options

Going Against the Graine: Triptans and Cardiovascular Disease

A Brighter Future: Exploring the Role of Brentuximab vedotin in Pediatric Hodgkin’s Lymphoma

Transplanting New Ideas: Updates in Cytomegalovirus Prophylaxis Solid Organ Transplantation

Infusion Confusion: Defining the Role of Prolonged Infusion Beta-Lactams

Breathing New Life into COPD Exacerbation Management

Pumping Iron: IV Iron Replacement in HFrEF

Buprenorphine for Opioid Use Disorders: Should you Stop Periop?

Infectious Risk with Advanced Therapies in Inflammatory Bowel Disease

Starving for Answers: Parenteral Nutrition in the Critically Ill

Statin Intolerance and Clear Alternatives

Nirsevimab: Prevent RSV or Let it Be?

Starting off STRONG: Optimizing Heart Failure Treatment at Transitions of Care

When Drugs BITE Back: Managing Toxicities of Bispecific T-Cell Engagers

Colchi(seen) to Reduce Cardiovascular Risk in Established ASCVD

It’s Not All Negative: Antibody Drug Conjugates in HER-2 Low Breast Cancer

The Intensive Approach: Updates for Blood Pressure Control in Intracerebral Hemorrhage

My, Oh, Myocarditis: More to Monitor for Clozapine?

Going Viral! Reactivation of Viral Infections Following Cancer Treatment

Don’t Lose Your Nerve: Supporting the Denervated Heart after Cardiac Transplantation

Shocking Update: The Use of Fludrocortisone in Septic Shock

Bad Blood: Anemia Management Updates in the Setting of Chronic Kidney Disease

A Rumble in the Fungal Jungle: Review of the New Antifungal Agents

Lost in the ECMO Chamber: Pharmacokinetics in Critical Illness

Must be mAb on the Brain: A New Hope for Alzheimer’s Disease

GPS for APS: Navigating Anticoagulation in Antiphospholipid Syndrome

Waving Goodbye to the X Waiver: Reassessing Medication Treatment for Opioid Use Disorder

Give it a Shot! Long-Acting Injectables in HIV Therapy

Taking the LEAD? Dual Pathway Inhibition Therapy for Lower Extremity Arterial Disease

What’s Been ‘Flozin On: Updates in Outpatient Management of Chronic Kidney Disease

Celebrating diversity: challenges and strategies to promote pharmacogenomics translation across populations

What’s the Best for CRS?

Pitter Patter, Let’s Get ATTR: Medications for Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Updates on the Clozapine REMS Program: An Important Relic or Fool’s Gold of Safety?

On Another Level: The Role of Therapeutic Drug Monitoring in Inflammatory Bowel Disease

All-In on Insulin? Use of High-Dose Insulin Euglycemic Therapy in Calcium Channel Blocker Overdose

Measuring Value in Drug Therapy

Verification Decision Support: May AI Take Your Order?

A Hard-Pressed Debate: The Role of Terlipressin in Hepatorenal Syndrome

Freezing Ethylene Glycol Toxicity

Emerging Antibiotics – Tetra(cycle)ine Back to Basics

Pharmacotherapy for the Treatment of Obesity

Off the Chain: The Drug Supply Chain and Medication Shortages

Clostridioides difficile Infection: Do We C the Diff-erence in Preventing Recurrence?

Pharmacologic Treatment of Drug Resistant Hypercholesterolemia

It’s Going Tibia Okay: Supportive Bone Health in Oncology

Other shows like Mayo Clinic Pharmacy Grand Rounds: